Chemotherapy and/or immune checkpoint inhibitors in NSCLC first-line setting: what is the best approach?
Gravara, Luigi Della, Battiloro, Ciro, Cantile, Rosa, Letizia, Antonietta, Vitiello, Fabiana, Montesarchio, Vincenzo, Rocco, DaniloVolume:
9
Journal:
Lung Cancer Management
DOI:
10.2217/lmt-2019-0018
Date:
March, 2020
File:
PDF, 544 KB
2020